Citius Pharmaceuticals, Inc.
Recent Filings
All 617 filings →| Form | Description | Date |
|---|---|---|
| 8-K | CURRENT REPORT | Mar 10, 2026 |
| 8-K | CURRENT REPORT | Mar 4, 2026 |
| ARS | FORM ARS | Feb 24, 2026 |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | Feb 24, 2026 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Feb 24, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| 8-K | CURRENT REPORT | Feb 13, 2026 |
| 10-Q | QUARTERLY REPORT | Feb 13, 2026 |
| 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | Jan 28, 2026 |
| 8-K | CURRENT REPORT | Dec 23, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| HOLUBIAK MYRON Z | President and CEO | Purchase | 558,597 @ $0.90 | 1,992,243 | Sep 27, 2019 |
| Mazur Leonard L | Executive Chairman | Purchase | 2,234,700 @ $0.90 | 10,255,343 | Sep 27, 2019 |
| HOLUBIAK MYRON Z | President and CEO | Purchase | 129,450 @ $1.55 | 1,433,646 | Apr 3, 2019 |
| Mazur Leonard L | Executive Chairman | Purchase | 1,165,048 @ $1.55 | 8,020,643 | Apr 3, 2019 |
| HOLUBIAK MYRON Z | President and CEO | Purchase | 784,314 @ $1.28 | 1,304,196 | Aug 13, 2018 |
| Mazur Leonard L | Executive Chairman | Purchase | 3,137,255 @ $1.28 | 6,855,595 | Aug 13, 2018 |
| Mazur Leonard L | Executive Chairman | Purchase | 167,504 @ $2.99 | 3,718,340 | Mar 29, 2018 |
| HOLUBIAK MYRON Z | President and CEO | Purchase | 2,915 @ $3.09 | 519,882 | Mar 28, 2018 |
| Mazur Leonard L | Executive Chairman | Purchase | 213,106 @ $4.69 | 3,550,836 | Dec 19, 2017 |
| Mazur Leonard L | Executive Chairman | Purchase | 11,000 @ $2.68 | 3,337,730 | Aug 24, 2017 |